Stocks and Investing
Stocks and Investing
Mon, August 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, August 6, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Salveen Richter Maintained (ADPT) at Hold with Decreased Target to $52 on, Aug 6th, 2021
Salveen Richter of Goldman Sachs, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $59 to $52 on, Aug 6th, 2021.
Salveen has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $55 on, Friday, May 7th, 2021
Contributing Sources